The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis

Journal of Clinical Immunology

Volumn 26, Issue 4, 2006, Pages 370-375

  Caproni, Marzia ^a   Torchia, Daniele ^a   Antiga, Emiliano ^a   Volpi, Walter ^a   Bianco, Elena Del ^a   Fabbri, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Atopic dermatitis; Hydrocortisone butyrate; T regulatory cells; Tacrolimus; TGF

Indexed keywords

BASILIXIMAB; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; INTERLEUKIN 10; LOCOIDON; OKT 4; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN BIOPSY; STAINING;

ADULT; BIOPSY; CHRONIC DISEASE; DERMATITIS, ATOPIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; MALE; MIDDLE AGED; OINTMENTS; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745899016     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9034-2     Document Type: Article

References (26)

1. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid Q: New insights into atopic dermatitis. J Clin Invest 113:651-657, 2004
2. Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol 3:253-257, 2003
3. Goleva E, Cardona ID, Ou LS, Leung DY: Factors that regulate naturally occurring T regulatory cell-mediated suppression. J Allergy Clin Immunol 116:1094-1100, 2005
4. Taylor A, Verhagen J, Akdis CA, Akdis M: T regulatory cells and allergy. Microbes and Infection 7:1049-1055, 2005
5. Ou LS, Goleva E, Hall MS, Leung DY: T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 113:756-763, 2004
6. Vukmanovic-Stejic M, McQuaid A, Birch KE, Reed JR, Macgregor C, Rustin MHA, Akbar AN: Relative impact of CD4+ CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. Br J Dermatol 153:750-757, 2005
7. Verhagen J, Akdis M, Traidl-Hoffmann C, Schmid-Grendelmeier P, Hijnen D, Knol EF, Behrendt H, Blaser K, Akdis CA: Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol 117:176-183, 2006
8. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC: Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trias. Br Med J 330:516-522, 2005
9. Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis: The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151(Suppl 70):3-27, 2004
10. Baan CC, van der Mast BJ, Klepper M, Mol WM, Peeters AM, Korevaar SS, Balk AK, Weimar W: Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 80:110-117, 2005
11. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis: Acta Derm. Venereol (Stockh) Suppl 92:44-17, 1980
12. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A: Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195:10-19, 1997
13. Caproni M, Giomi B, Volpi W, Melani L, Schincaglia E, Macchia D, Manfredi M, D'Agata A, Fabbri P: Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin Immunol 114:284-292, 2005
14. Leung DY: Atopic dermatitis: new insights and opportunities for therapeutic interventions. J Allergy Clin Immunol 105:860-876, 2000
15. Simon D, Vassina E, Yousefi S, Kozlowski E, Braathen LR, Simon HU: Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment. J Allergy Clin Immunol 114:887-895, 2004
16. Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T: Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 107:519-525, 2001
17. Akdis M, Akdis CA, Weigl L, Disch R, Blaser K: Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol 159:4611-4619, 1997
18. Knoechel B, Lohr J, Kahn E, Bluestone JA, Abbas AK: Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med 202:1375-1386, 2005
19. Wraith DC: Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells. J Autoimmun 20:273-275, 2003
20. Simon D, Vassina E, Yousefi S, Braathen LR, Simon HU: Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. Allergy 60:944-951, 2005
21. Peek EJ, Richards DF, Faith A, Lavender P, Lee TH, Corrigan CJ, Havrylowicz CM: Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonist. Am J Respir Cell Mol Biol 33:105-111, 2005
22. Aoki CA, Borchers AT, Li M, Flavell RA, Bowlus CL, Ansari AA, Gershwin ME: Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun Rev 4:450-459, 2005
23. Arkwright PD, Chase JM, Babbage S, Pravica V, David TJ, Hutchinson IV: Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol 108:281-284, 2001
24. Lee HJ, Lee HP, Ha SJ, Byun DG, Kim JW: Spontaneous expression of mRNA for IL-10, GM-CSF, TGF-beta, TGF-alpha, and IL-6 in peripheral blood mononuclear cells from atopic dermatitis. Ann Allergy Asthma Immunol 84:553-558, 2000
25. Lan CC, Kao YH, Huang SM, Yu HS, Chen GS: FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin. Br J Dermatol 151:679-684, 2004
26. Khanna AK: The immunosuppressive agent tacrolimus induces p21WAF/CIP1WAF1/CIP1 via TGF-beta secretion. Biochem Biophys Res Commun 303:266-272, 2003